Joan J. Ryoo
- Hematology top 2%
- Molecular Biology
- Oncology top 10%
- Genetics top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Kenneth C. AndersonTeru HideshimaAndrea FreemanFaith E. DaviesLaurence CatleyRebecca L. RichEdie WellerDeborah Doss
- Topics
- Global Cancer Incidence and Screening (4 papers)Palliative Care and End-of-Life Issues (4 papers)Multiple Myeloma Research and Treatments (3 papers)
- Cited by
- HematologyOncologyGenetics
- Journals
- Journal of Clinical OncologyBloodInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- United StatesAustralia
In The Last Decade
Joan J. Ryoo
18 papers receiving 837 citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Hematology 572
- Molecular Biology 476
- Oncology 427
- Genetics 107
- Pulmonary and Respiratory Medicine 101
Countries citing papers authored by Joan J. Ryoo
This map shows the geographic impact of Joan J. Ryoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan J. Ryoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan J. Ryoo more than expected).
Fields of papers citing papers by Joan J. Ryoo
This network shows the impact of papers produced by Joan J. Ryoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan J. Ryoo. The network helps show where Joan J. Ryoo may publish in the future.
Co-authorship network of co-authors of Joan J. Ryoo
This figure shows the co-authorship network connecting the top 25 collaborators of Joan J. Ryoo. A scholar is included among the top collaborators of Joan J. Ryoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan J. Ryoo. Joan J. Ryoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 20 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 14 | |
| 7 | 1 | |
| 8 | 13 | |
| 9 | 2 | |
| 10 | Validating electronic cancer quality measures at Veterans Health Administration. | 9 |
| 11 | 28 | |
| 12 | 69 | |
| 13 | 12 | |
| 14 | 3 | |
| 15 | 34 | |
| 16 | 1 | |
| 17 | 6 | |
| 18 | Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myelomabreakdown → | 630 |
| 19 | A phase 1 study of oral CC5013, an immunomodulatory thalidomide (Thal) derivative, in patients with relapsed and refractory multiple myeloma (MM). | 23 |
About Joan J. Ryoo
Joan J. Ryoo is a scholar working on Otorhinolaryngology, Oncology and Hematology, having authored 19 papers that have together received 872 indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (4 papers), Palliative Care and End-of-Life Issues (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (572 citations), Oncology (427 citations) and Genetics (107 citations). Joan J. Ryoo has collaborated with scholars based in United States and Australia. Frequent co-authors include Kenneth C. Anderson, Teru Hideshima, Andrea Freeman, Faith E. Davies, Laurence Catley, Rebecca L. Rich, Edie Weller, Deborah Doss, Jerome B. Zeldis and Richard LeBlanc. Their work appears in journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.